Ekttitab Holding Co. K.S.C. Reduces Capital to Offset Accumulated Losses

Ekttitab Holding Co. K.S.C. has announced a significant capital reduction to offset its accumulated losses, following approval from the Capital Markets Authority. The company disclosed this financial move on November 19, 2026, as part of its strategic restructuring efforts.

The Capital Markets Authority has sanctioned a reduction in Ekttitab Holding's capital from KWD 31,862,423 to KWD 8,131,223. This decision results in a capital decrease of KWD 23,731,200, aimed at covering the company's accumulated losses of KWD 23,825,706, according to the audited financial statements for the year ended December 31, 2025.

The capital reduction involves the cancellation of 237,312,000 shares, each with a nominal value of 100 fils, representing 74.48% of the company's capital. Additionally, the statutory reserve amounting to KWD 94,506 will be entirely canceled as part of this financial adjustment.

According to information available from the Dubai Financial Market (DFM), the financial impact of this corporate action will be disclosed once all related procedures are finalized and necessary approvals are obtained. Ekttitab Holding Co. K.S.C. plans to announce the confirmed date for the Corporate Action Timetable upon completion of all required processes.

This move follows a previous disclosure made on May 5, 2026, concerning the write-off of accumulated losses and capital reduction. The company continues to navigate these financial adjustments in accordance with Chapter Four of Book Ten of the Executive Regulations of the Capital Markets Authority Law, focusing on disclosure and transparency in material information.